Bio-Rad Laboratories (BIO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Bio-Rad Laboratories (BIO) is Neutral.

The composite score behind that read is +0.03, weighing +0.13 of bullish evidence against -0.29 bearish.

Bio-Rad Laboratories last closed at $366.16, +1.60% on the session.

Against the IVW growth benchmark the position is +0.80% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

16 graded predictions for BIO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Bio-Rad Laboratories in the 17th percentile on valuation and the 45th percentile on return on equity, where 100 is best.

Bio-Rad Laboratories is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $7.81B.

StockMap tracks Bio-Rad Laboratories as the 20th largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Bio-Rad Laboratories ranks 26th of 41 in the group, against a group median of +0.06.